Shenzhen Senboll Biotechnology Co., Ltd is a by scientists in Europe and the United States more than 20 years engaged Senboll is a high-tech company which was founfed in 2017. after the first international contest winners started to focus on the digestive tract disease related detection and early cancer detection, have independent intellectual property rights of innovative high-tech enterprises, Located in Shenzhen Pingshan National Biome
Chief scientist, Dr JIAN GUO, who has over 20 years experiences in searching novel biomarkers in the field of GI disorders in vitro diagnosis.
Our Vision: We have passionate about improving health outcomes for individuals with GI disorders.
Our mission: We help clinicians to get their patients with complex diseases diagnosis and in remission faster using precision-guided care.
*Class A overseas high-level talent of Shenzhen Administration of Foreign Experts Affairs;
*"Julong Talent" of Pingshan District, Shenzhen;
*Visiting professor of Shenzhen University of Technology;
*Graduated from Harbin Medical University;
*PhD in molecular biology from Leiden University;
*Harvard University and Duke University, Postdoctoral Fellow;
*Senior Researcher, University of Toronto;
*R&D Director of GeneNews Biotech Inc., Canada;
*Senior Researcher/Research Assistant Professor, University of Toronto;
*Founded Senboll Biotechnology Inc in Toronto, Canada in 2015;
My uncle was a doctor who brought me up when I was young. His words and actions had a subtle influence on me when I was young. I was determined to be a doctor when I grew up and wanted to save patients by my own hands. However, his dream turned into reality. He did not become a doctor after graduating from a domestic medical school. Instead, he went to Leiden University, Einstein's Alma mater, to study for a doctorate and became a researcher in life science. Life is like a book, birth is the cover, return is the back cover, the content to rely on yourself to fill. Our generation has been educated in patriotism since childhood. From Europe to the United States and Canada, we have been obsessed with the research we pursue in our hearts during the past twenty years overseas. We hope that one day we can make a success of our studies and return to our motherland to serve the society, which is our greatest ideal and comfort.In 2017, after winning the first international competition of Shenzhen Innovation Competition, he came to Shenzhen to establish an innovative enterprise focusing on the diagnosis of gastrointestinal diseases and their early cancer and signs. He changed his way to save more lives.The incidence of digestive tract diseases is high in the world, and the clinical manifestations are complex. Some malignant tumors have hidden onset, and there are still many difficulties in early detection. Through down-to-earth research, we led the team to spend many years searching for more than 25,000 genes in human beings, and verified by layers of large samples of serum. Several OF THE MOST specific AND SENSITIVE protein MARKERS of SEROLOGY-related digestive DISEASES HAVE BEEN IDENTIFIED, WHICH COULD HELP DOCTORS MAKE DIAGNOSIS AND TREATMENT DECISIONS MORE EASILY AND allow life to CONTINUE MORE easily.On the road of independent innovation all the way, Piper, thorns, although rugged, but has been adhering to the original intention, unswervingly adhering to the society to provide "accurate, simple, fast, economic" products, along with the trend, abide by ingenuity, practice.Sheng Bohr, life science and technology is a pursuit of a long-term and sustainable development of enterprises, we firmly believe that talent is the soul of enterprise development, the source of development, we have a foothold domestic, face international, through continuous innovation, research and development more popular products, together with colleagues, line zhiyuan, create value, and look forward to rewrite the human health history together.